Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate the efficacy, safety, and tolerability of remibrutinib in adults and adolescents with mod…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Ongoing Phase 3 trial update examining long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in adults with moderate to s…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
A real-world study evaluating outcomes in patients with hidradenitis suppurativa and high cardiovascular risk or established coronary plaque…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Bioelectric Dressing for Post De-Roofing Treatment of HS [NA]
A completed clinical trial evaluated a bioelectric dressing as a post-de-roofing treatment for hidradenitis suppurativa. Results have been p…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Zasocitinib in Adults With Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating Zasocitinib in adults with hidradenitis suppurativa is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]
Phase 2 study evaluating the efficacy and safety of Brensocatib in adults with moderate to severe hidradenitis suppurativa. The trial status…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
This clinical trial update describes a regulatory post-marketing surveillance study of Secukinumab (Cosentyx) in Korean patients with hidrad…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy [Phase 3]
A Phase 3 clinical trial evaluating oral upadacitinib in adults and adolescents with moderate-to-severe hidradenitis suppurativa who failed …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Hidradenitis - an Analysis of Genetic Traits and Linkages in Families
A University of Chicago-led clinical trial analyzing genetic traits and linkages in families affected by hidradenitis suppurativa has been t…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: The Ohio State University Dermatology Biorepository
The Ohio State University Dermatology Biorepository is currently recruiting participants for hidradenitis suppurativa research.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
The clinical trial evaluating an AI diagnostic tool for primary care doctors assessing skin conditions has been completed. The study evaluat…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa [Phase 1]
Phase 1 study update showing single-dose evaluation of SBT777101 in adults with hidradenitis suppurativa; the trial is currently active but …
-
EMA approval · 2026-02-19EMA Authorised: Hulio (adalimumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Hulio, a biosimilar of adalimumab, for multiple inflammatory indications including hidradenitis suppurativa, psoriasis, u…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Myriad™ Augmented Soft Tissue Reconstruction Registry
Clinical trial update for the Myriad Augmented Soft Tissue Reconstruction Registry, currently recruiting across multiple wound-related indic…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating QLS12010 capsules in adults with moderate-to-severe hidradenitis suppurativa; the study is currently not r…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Radiotherapy for Refractory Hidradenitis Suppurativa [NA]
This clinical trial update notes that Thomas Jefferson University is evaluating radiotherapy for refractory hidradenitis suppurativa. The st…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anifrolumab for Hidradenitis Suppurativa [Phase 2]
Phase 2 trial investigating anifrolumab for hidradenitis suppurativa is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa [EARLY_Phase 1]
University of Minnesota-sponsored early Phase 1 trial is evaluating Capsule Microbiota Transplant Therapy for hidradenitis suppurativa and i…
-
EMA approval · 2026-02-16EMA Authorised: Hefiya (adalimumab) — Sandoz GmbH
EMA authorised Hefiya, a biosimilar adalimumab from Sandoz GmbH, for multiple inflammatory conditions including ankylosing spondylitis, hidr…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
A real-world, global study to assess disease burden in adolescents and adults with alopecia areata, vitiligo, or hidradenitis suppurativa.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy [Phase 2]
An update on a Phase 2 study evaluating subcutaneous lutikizumab (ABT-981) for hidradenitis suppurativa. The trial assesses disease activity…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense [Phase 2]
Phase 2 clinical trial evaluating tibulizumab for skin healing and inflammation in hidradenitis suppurativa is currently recruiting. No resu…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: The Safety and Efficacy of Roflumilast Foam in HS [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of Roflumilast Foam for hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 study evaluating the efficacy and safety of povorcitinib (INCB054707) in adults with moderate-to-severe hidradenitis suppurativa h…